The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

https://www.wired.com/story/novo-nordisk-ozempic-compounded-fda-block-pharmacies Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders. Powered by VoiceFeed. https://voicefeed.web.app/lp/podcast?utm_source=apple_technews&utm_medium=podcast Developer:https://twitter.com/_horotter